 |
市場調查報告書
商品編碼
1511600
動脈切開術用閉合裝置的開發平台 - 開發階段，市場區隔，地區和國家，法規途徑，主要企業(2024年版)Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update |
||||||
價格
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
簡介目錄
本報告提供動脈切開術用閉合裝置的開發中產品調查分析，提供涵括各種處於開發階段產品的比較分析，及進行中的臨床試驗等全面性資訊。
目錄
第1章 目錄
第2章 簡介
第3章 開發中的產品
- 動脈切開術用閉合裝置 - 開發中產品:各開發階段
- 動脈切開術用閉合裝置 - 開發中產品:各市場區隔
- 動脈切開術用閉合裝置 - 開發中產品:各地區
- 動脈切開術用閉合裝置 - 開發中產品:各法規途徑
- 動脈切開術用閉合裝置 - 開發中產品:估計核准日
- 動脈切開術用閉合裝置 - 進行中的臨床試驗
第4章 動脈切開術用閉合裝置 - 各公司的正在開發的開發中產品
- 動脈切開術用閉合裝置企業 - 開發中產品:各開發階段
- 動脈切開術用閉合裝置 - 開發中產品:各開發階段
第5章 動脈切開術用閉合裝置的企業和產品概要
- Aporo Biomedical, Inc.(暫停中):企業概要
- Aporo Biomedical, Inc.(暫停中):開發中產品和進行中的臨床試驗概要
- Arterica Inc:企業概要
- Arterica Inc:開發中產品和進行中的臨床試驗概要
- CardioDex Ltd(暫停中):企業概要
- CardioDex Ltd(暫停中):開發中產品和進行中的臨床試驗概要
- CaveoMed GmbH:企業概要
- CaveoMed GmbH:開發中產品和進行中的臨床試驗概要
- CloSys Corp:企業概要
- CloSys Corp:開發中產品和進行中的臨床試驗概要
- CPC of America Inc:企業概要
- CPC of America Inc:開發中產品和進行中的臨床試驗概要
- CyndRX LLC:企業概要
- CyndRX LLC:開發中產品和進行中的臨床試驗概要
- Dextera Surgical Inc:企業概要
- Dextera Surgical Inc:開發中產品和進行中的臨床試驗概要
- Genesis MedTech International Pvt Ltd:企業概要
- Genesis MedTech International Pvt Ltd:開發中產品和進行中的臨床試驗概要
- Harvard University:企業概要
- Harvard University:開發中產品和進行中的臨床試驗概要
- Lepu Medical Technology (北京) Co Ltd:企業概要
- Lepu Medical Technology (北京) Co Ltd:開發中產品和進行中的臨床試驗概要
- 南京市 SealMed Medical Technology Corp Ltd:企業概要
- 南京市 SealMed Medical Technology Corp Ltd:開發中產品和進行中的臨床試驗概要
- NewMed Medical Co Ltd:企業概要
- NewMed Medical Co Ltd:開發中產品和進行中的臨床試驗概要
- ProMed Inc:企業概要
- ProMed Inc:開發中產品和進行中的臨床試驗概要
- Rex Medical LP:企業概要
- Rex Medical LP:開發中產品和進行中的臨床試驗概要
- Shanghai HeartCare Medical Technology Co Ltd:企業概要
- Shanghai HeartCare Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要
- Spiorad Medical Ltd:企業概要
- Spiorad Medical Ltd:開發中產品和進行中的臨床試驗概要
- Terumo Interventional Systems:企業概要
- Terumo Interventional Systems:開發中產品和進行中的臨床試驗概要
- University of Rochester:企業概要
- University of Rochester:開發中產品和進行中的臨床試驗概要
- Vascular Closure Systems Inc:企業概要
- Vascular Closure Systems Inc:開發中產品和進行中的臨床試驗概要
- Vivasure Medical Ltd.:企業概要
- Vivasure Medical Ltd.:開發中產品和進行中的臨床試驗概要
- Zylox-Tonbridge Medical Technology Co Ltd:企業概要
- Zylox-Tonbridge Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要
第6章 動脈切開術用閉合裝置 - 近幾年的發展
- 2024 年 4 月 15 日：Vivasure Medical 宣布首例下腔靜脈患者接受 PerQseal Elite 血管閉合系統治療
- 2023 年 12 月 12 日：Vivasure Medical 宣布首位患者接受 PerQseal Elite 閉合裝置系統治療
- 2023 年 11 月 17 日：泰利福在 MANTA 設備試驗中招募了第一位患者
- 2023 年 11 月 14 日：Vivasure Medical 宣布第 100 名患者參加了美國重大研究
- 2023 年 8 月 29 日：Haemonetics 宣佈在歐洲推出 VASCADE 血管閉合系統
第7章 附錄
簡介目錄
Product Code: GDME1760EPD
GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Arteriotomy Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Arteriotomy Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Arteriotomy Closure Devices Overview
3 Products under Development
- 3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
- 3.2 Arteriotomy Closure Devices - Pipeline Products by Segment
- 3.3 Arteriotomy Closure Devices - Pipeline Products by Territory
- 3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
- 3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
- 3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials
4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies
- 4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
- 4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
5 Arteriotomy Closure Devices Companies and Product Overview
- 5.1 Aporo Biomedical, Inc. (Inactive) Company Overview
- 5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Arterica Inc Company Overview
- 5.2.1 Arterica Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 CardioDex Ltd (Inactive) Company Overview
- 5.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 CaveoMed GmbH Company Overview
- 5.4.1 CaveoMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 CloSys Corp Company Overview
- 5.5.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 CPC of America Inc Company Overview
- 5.6.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 CyndRX LLC Company Overview
- 5.7.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 Dextera Surgical Inc Company Overview
- 5.8.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 Genesis MedTech International Pvt Ltd Company Overview
- 5.9.1 Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Harvard University Company Overview
- 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Lepu Medical Technology (Beijing) Co Ltd Company Overview
- 5.11.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 Nanjing SealMed Medical Technology Corp Ltd Company Overview
- 5.12.1 Nanjing SealMed Medical Technology Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 NewMed Medical Co Ltd Company Overview
- 5.13.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 ProMed Inc Company Overview
- 5.14.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 Rex Medical LP Company Overview
- 5.15.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 Shanghai HeartCare Medical Technology Co Ltd Company Overview
- 5.16.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Spiorad Medical Ltd Company Overview
- 5.17.1 Spiorad Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 Terumo Interventional Systems Company Overview
- 5.18.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 University of Rochester Company Overview
- 5.19.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 Vascular Closure Systems Inc Company Overview
- 5.20.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Vivasure Medical Ltd. Company Overview
- 5.21.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 5.22 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
- 5.22.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Arteriotomy Closure Devices- Recent Developments
- 6.1 Apr 15, 2024: Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
- 6.2 Dec 12, 2023: Vivasure Medical Announces First Patients Treated with PerQseal Elite Closure Device System
- 6.3 Nov 17, 2023: Teleflex enrols first patient in MANTA device trial
- 6.4 Nov 14, 2023: Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study
- 6.5 Aug 29, 2023: Haemonetics Announces European Expansion for VASCADE Vascular Closure System
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
